Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natan Lishinsky-Fischer

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Retina (Philadelphia, Pa.)|June 17, 2026
PROSTACYCLIN ANALOGS AND DIABETIC RETINOPATHY OUTCOMES IN PATIENTS WITH PULMONARY HYPERTENSION : A Cohort AnalysisNatan Lishinsky-Fischer, Jaime Levy
Eye (London, England)|March 3, 2026
Response to: 'Comment on 'Systemic prostacyclin analogues in pulmonary hypertension are associated with reduced risk of age-related macular degeneration: a cohort study"Elad Eilon, Natan Lishinsky-Fischer, Jaime Levy
Retina (Philadelphia, Pa.)|May 19, 2025
The effects of immunosuppressive therapy for immune-mediated inflammatory disease on the risk of age-related macular degenerationNatan Lishinsky-Fischer, Itay Chowers, Jaime Levy
Eye (London, England)|November 4, 2025
Systemic prostacyclin analogues in pulmonary hypertension are associated with reduced risk of age-related macular degeneration: a cohort studyElad Eilon, Natan Lishinsky-Fischer, Jaime Levy
Thyroid : Official Journal of the American Thyroid Association|April 9, 2026
Teprotumumab-Associated Hyperglycemia: A Large-Scale Multinational Cohort StudyNatan Lishinsky-Fischer, Rena Pollack, Zvi Gur
Ophthalmology Science|February 3, 2025
Patients with Age-related Macular Degeneration Have Increased Susceptibility to Valvular Heart DiseaseNatan Lishinsky-Fischer, Itay Chowers, Yahel Shwartz, et al.
Eye (London, England)|February 5, 2026
Biologic therapy is associated with reduced ocular disease in psoriasis: a real-world studyShoham Kubovsky, Natan Lishinsky-Fischer, Itay Chowers, et al.
American Journal of Ophthalmology|January 9, 2026
Reduced Risk of Non-Neovascular AMD in Cancer Patients Treated with Immune Checkpoint Inhibitors: A Propensity-Matched Cohort StudyNatan Lishinsky-Fischer, Sima Gharra, Itay Nitzan, et al.
Journal of Ophthalmic Inflammation and Infection|June 3, 2026
Eosinophilic esophagitis is associated with increased risk of allergic conjunctivitis: a multicenter cohort studyNatan Lishinsky-Fischer, Daniel Burg, Shoham Kubovsky, et al.
Ophthalmology Science|September 8, 2025
Longitudinal Assessment of Age-Related Macular Degeneration and Risk of Dementia Using Clinical Setting DataNatan Lishinsky-Fischer, Yaacov Cnaany, Itay Nitzan, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Retina (Philadelphia, Pa.)|June 17, 2026
PROSTACYCLIN ANALOGS AND DIABETIC RETINOPATHY OUTCOMES IN PATIENTS WITH PULMONARY HYPERTENSION : A Cohort AnalysisNatan Lishinsky-Fischer, Jaime Levy
Eye (London, England)|March 3, 2026
Response to: 'Comment on 'Systemic prostacyclin analogues in pulmonary hypertension are associated with reduced risk of age-related macular degeneration: a cohort study"Elad Eilon, Natan Lishinsky-Fischer, Jaime Levy
Retina (Philadelphia, Pa.)|May 19, 2025
The effects of immunosuppressive therapy for immune-mediated inflammatory disease on the risk of age-related macular degenerationNatan Lishinsky-Fischer, Itay Chowers, Jaime Levy
Eye (London, England)|November 4, 2025
Systemic prostacyclin analogues in pulmonary hypertension are associated with reduced risk of age-related macular degeneration: a cohort studyElad Eilon, Natan Lishinsky-Fischer, Jaime Levy
Thyroid : Official Journal of the American Thyroid Association|April 9, 2026
Teprotumumab-Associated Hyperglycemia: A Large-Scale Multinational Cohort StudyNatan Lishinsky-Fischer, Rena Pollack, Zvi Gur
Ophthalmology Science|February 3, 2025
Patients with Age-related Macular Degeneration Have Increased Susceptibility to Valvular Heart DiseaseNatan Lishinsky-Fischer, Itay Chowers, Yahel Shwartz, et al.
Eye (London, England)|February 5, 2026
Biologic therapy is associated with reduced ocular disease in psoriasis: a real-world studyShoham Kubovsky, Natan Lishinsky-Fischer, Itay Chowers, et al.
American Journal of Ophthalmology|January 9, 2026
Reduced Risk of Non-Neovascular AMD in Cancer Patients Treated with Immune Checkpoint Inhibitors: A Propensity-Matched Cohort StudyNatan Lishinsky-Fischer, Sima Gharra, Itay Nitzan, et al.
Journal of Ophthalmic Inflammation and Infection|June 3, 2026
Eosinophilic esophagitis is associated with increased risk of allergic conjunctivitis: a multicenter cohort studyNatan Lishinsky-Fischer, Daniel Burg, Shoham Kubovsky, et al.
Ophthalmology Science|September 8, 2025
Longitudinal Assessment of Age-Related Macular Degeneration and Risk of Dementia Using Clinical Setting DataNatan Lishinsky-Fischer, Yaacov Cnaany, Itay Nitzan, et al.
Pageof 2